{"id":43996,"date":"2025-10-21T20:48:01","date_gmt":"2025-10-21T12:48:01","guid":{"rendered":"https:\/\/flcube.com\/?p=43996"},"modified":"2025-10-21T20:48:02","modified_gmt":"2025-10-21T12:48:02","slug":"advaccine-biotechnology-announces-private-placement-of-up-to-2-2-million-shares-to-raise-rmb-300-million-for-microneedle-vaccine-development","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43996","title":{"rendered":"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development"},"content":{"rendered":"\n<p>Advaccine Biotechnology (NEEQ:\u202f874055) today disclosed a private placement offering of no more than <strong>2,203,200 shares<\/strong> at <strong>RMB\u202f136.17 per share<\/strong>, aiming to generate <strong>up to RMB\u202f300\u202fmillion<\/strong> in proceeds. The capital will be earmarked for expanding the company\u2019s cutting\u2011edge microneedle manufacturing capabilities, accelerating R&amp;D, and strengthening liquidity.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-allocation-of-proceeds\">Allocation of Proceeds<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Use of Funds<\/th><th>Amount (RMB\u202fmillion)<\/th><\/tr><\/thead><tbody><tr><td>Pilot\u2011scale &amp; commercial microneedle workshops<\/td><td>70<\/td><\/tr><tr><td>R&amp;D working capital<\/td><td>100<\/td><\/tr><tr><td>Routine operating expenses<\/td><td>90<\/td><\/tr><tr><td>Loan &amp; bank borrowing repayment<\/td><td>40<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-platforms-amp-product-pipeline\">Technology Platforms &amp; Product Pipeline<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Antigen Discovery Platform<\/strong> \u2013 Enables rapid identification of immunogenic targets across infectious and oncologic indications.<\/li>\n\n\n\n<li><strong>Adjuvant Technology Platform<\/strong> \u2013 Enhances immune potency of vaccine candidates.<\/li>\n\n\n\n<li><strong>Drug Delivery Platform<\/strong> \u2013 Focused on <strong>soluble microneedle<\/strong> technology for painless, at\u2011home administration.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-key-product-highlights\">Key Product Highlights<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Product<\/th><th>Status<\/th><th>Notable Milestone<\/th><\/tr><\/thead><tbody><tr><td><strong>Soluble Microneedle OTC Acne<\/strong><\/td><td>FDA\u2011registered &amp; approved in the U.S.<\/td><td>First microneedle acne product on the market<\/td><\/tr><tr><td><strong>Soluble Microneedle OTC \u2013 Anti\u2011Wrinkle, Skin Anti\u2011Infection, Weight Loss<\/strong><\/td><td>In development<\/td><td>Expanding OTC portfolio<\/td><\/tr><tr><td><strong>ADV110 (RSV Vaccine)<\/strong><\/td><td>Phase II completed<\/td><td>Met all primary endpoints; moving to Phase III<\/td><\/tr><tr><td><strong>ADV2401 (Melanoma), ADV2402 (Breast Cancer), ADV2403 (Osteosarcoma)<\/strong><\/td><td>Preclinical<\/td><td>Demonstrated significant tumor inhibition<\/td><\/tr><tr><td><strong>ADV2104 (RRP Vaccine)<\/strong><\/td><td>FDA\u2011RPDD<\/td><td>First therapeutic for Recurrent Respiratory Papillomatosis to receive Rare Pediatric Disease Designation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-outlook\">Strategic Outlook<\/h2>\n\n\n\n<p>Advaccine\u2019s capital raise will accelerate the transition from pilot to commercial scale, support high\u2011impact R&amp;D, and fortify the company\u2019s balance sheet. With FDA\u2011approved products and a robust pipeline, Advaccine is positioned to become a global leader in microneedle\u2011based vaccines and therapeutics.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\"><strong>Forward\u2011Looking Statements<\/strong><\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Advaccine Biotechnology (NEEQ:\u202f874055) today disclosed a private placement offering of no more than 2,203,200 shares&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43998,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2964],"class_list":["post-43996","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-advaccine-biotechnology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Advaccine Biotechnology (NEEQ:\u202f874055) today disclosed a private placement offering of no more than 2,203,200 shares at RMB\u202f136.17 per share, aiming to generate up to RMB\u202f300\u202fmillion in proceeds. The capital will be earmarked for expanding the company\u2019s cutting\u2011edge microneedle manufacturing capabilities, accelerating R&amp;D, and strengthening liquidity.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43996\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development\" \/>\n<meta property=\"og:description\" content=\"Advaccine Biotechnology (NEEQ:\u202f874055) today disclosed a private placement offering of no more than 2,203,200 shares at RMB\u202f136.17 per share, aiming to generate up to RMB\u202f300\u202fmillion in proceeds. The capital will be earmarked for expanding the company\u2019s cutting\u2011edge microneedle manufacturing capabilities, accelerating R&amp;D, and strengthening liquidity.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43996\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-21T12:48:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-21T12:48:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2103.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development\",\"datePublished\":\"2025-10-21T12:48:01+00:00\",\"dateModified\":\"2025-10-21T12:48:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996\"},\"wordCount\":294,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2103.webp\",\"keywords\":[\"Advaccine Biotechnology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43996#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43996\",\"name\":\"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2103.webp\",\"datePublished\":\"2025-10-21T12:48:01+00:00\",\"dateModified\":\"2025-10-21T12:48:02+00:00\",\"description\":\"Advaccine Biotechnology (NEEQ:\u202f874055) today disclosed a private placement offering of no more than 2,203,200 shares at RMB\u202f136.17 per share, aiming to generate up to RMB\u202f300\u202fmillion in proceeds. The capital will be earmarked for expanding the company\u2019s cutting\u2011edge microneedle manufacturing capabilities, accelerating R&D, and strengthening liquidity.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43996\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2103.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2103.webp\",\"width\":1080,\"height\":608,\"caption\":\"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle & Vaccine Development\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43996#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development - Insight, China&#039;s Pharmaceutical Industry","description":"Advaccine Biotechnology (NEEQ:\u202f874055) today disclosed a private placement offering of no more than 2,203,200 shares at RMB\u202f136.17 per share, aiming to generate up to RMB\u202f300\u202fmillion in proceeds. The capital will be earmarked for expanding the company\u2019s cutting\u2011edge microneedle manufacturing capabilities, accelerating R&D, and strengthening liquidity.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43996","og_locale":"en_US","og_type":"article","og_title":"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development","og_description":"Advaccine Biotechnology (NEEQ:\u202f874055) today disclosed a private placement offering of no more than 2,203,200 shares at RMB\u202f136.17 per share, aiming to generate up to RMB\u202f300\u202fmillion in proceeds. The capital will be earmarked for expanding the company\u2019s cutting\u2011edge microneedle manufacturing capabilities, accelerating R&D, and strengthening liquidity.","og_url":"https:\/\/flcube.com\/?p=43996","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-21T12:48:01+00:00","article_modified_time":"2025-10-21T12:48:02+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2103.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43996#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43996"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development","datePublished":"2025-10-21T12:48:01+00:00","dateModified":"2025-10-21T12:48:02+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43996"},"wordCount":294,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43996#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2103.webp","keywords":["Advaccine Biotechnology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43996#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43996","url":"https:\/\/flcube.com\/?p=43996","name":"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43996#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43996#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2103.webp","datePublished":"2025-10-21T12:48:01+00:00","dateModified":"2025-10-21T12:48:02+00:00","description":"Advaccine Biotechnology (NEEQ:\u202f874055) today disclosed a private placement offering of no more than 2,203,200 shares at RMB\u202f136.17 per share, aiming to generate up to RMB\u202f300\u202fmillion in proceeds. The capital will be earmarked for expanding the company\u2019s cutting\u2011edge microneedle manufacturing capabilities, accelerating R&D, and strengthening liquidity.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43996#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43996"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43996#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2103.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2103.webp","width":1080,"height":608,"caption":"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle & Vaccine Development"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43996#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Advaccine Biotechnology Announces Private Placement of Up to 2.2\u202fMillion Shares to Raise RMB\u202f300\u202fMillion for Microneedle &amp; Vaccine Development"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2103.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43996"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43996\/revisions"}],"predecessor-version":[{"id":43999,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43996\/revisions\/43999"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43998"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}